Skip to main content
. 2020 Nov 24;8(2):e001488. doi: 10.1136/jitc-2020-001488

Figure 1.

Figure 1

Time from the commencement of immunotherapy to the onset of symptoms of colitis in weeks with median and confidence intervals. Time to colitis by immunotherapy regimen (IPI +PD1 in blue vs PD1 in red; p=<0.001). PD1, programmed cell death protein 1; IPI, ipilimumab.